Cesium;bis(4-hydroxypent-3-en-2-one);2-[6-[6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;tetrakis(iridium);methanone;2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridin-1-ium;5-methyl-2-phenylquinoline;2-(2H-naphthalen-2-id-1-yl)pyridine;1-phenylisoquinoline;2-phenylquinoline;platinum
C103H84CsIr4N10O8Pt-5 — CID 159025360
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cesium;bis(4-hydroxypent-3-en-2-one);2-[6-[6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;tetrakis(iridium);methanone;2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridin-1-ium;5-methyl-2-phenylquinoline;2-(2H-naphthalen-2-id-1-yl)pyridine;1-phenylisoquinoline;2-phenylquinoline;platinum
Cesium;bis(4-hydroxypent-3-en-2-one);2-[6-[6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;tetrakis(iridium);methanone;2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridin-1-ium;5-methyl-2-phenylquinoline;2-(2H-naphthalen-2-id-1-yl)pyridine;1-phenylisoquinoline;2-phenylquinoline;platinum (PubChem CID 159025360) has the molecular formula C103H84CsIr4N10O8Pt-5 and a molecular weight of 2686.72 g/mol. Its IUPAC name is cesium;bis(4-hydroxypent-3-en-2-one);2-[6-[6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;tetrakis(iridium);methanone;2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridin-1-ium;5-methyl-2-phenylquinoline;2-(2H-naphthalen-2-id-1-yl)pyridine;1-phenylisoquinoline;2-phenylquinoline;platinum.
Molecular Properties
| Compound Name | Cesium;bis(4-hydroxypent-3-en-2-one);2-[6-[6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;tetrakis(iridium);methanone;2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridin-1-ium;5-methyl-2-phenylquinoline;2-(2H-naphthalen-2-id-1-yl)pyridine;1-phenylisoquinoline;2-phenylquinoline;platinum |
|---|---|
| PubChem CID | 159025360 |
| Molecular Formula | C103H84CsIr4N10O8Pt-5 |
| Molecular Weight | 2686.72 g/mol |
| Exact Mass | 2688.37 |
| IUPAC Name | cesium;bis(4-hydroxypent-3-en-2-one);2-[6-[6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;tetrakis(iridium);methanone;2-(5-methyl-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl)pyridin-1-ium;5-methyl-2-phenylquinoline;2-(2H-naphthalen-2-id-1-yl)pyridine;1-phenylisoquinoline;2-phenylquinoline;platinum |
| SMILES | CC(=O)C=C(C)O.CC(=O)C=C(C)O.Cc1cccc2nc(-c3[c-]cccc3)ccc12.Cc1n[n-]c(-c2cccc[nH+]2)n1.Oc1ccccc1-c1cccc(-c2cccc(-c3ccccc3O)n2)n1.[CH-]=O.[CH-]=O.[Cs+].[Ir].[Ir].[Ir].[Ir].[Pt].[c-]1ccc2ccccc2c1-c1ccccn1.[c-]1ccccc1-c1ccc2ccccc2n1.[c-]1ccccc1-c1nccc2ccccc12 |
| InChI | InChI=1S/C22H16N2O2.C16H12N.3C15H10N.C8H7N4.2C5H8O2.2CHO.Cs.4Ir.Pt/c25-21-13-3-1-7-15(21)17-9-5-11-19(23-17)20-12-6-10-18(24-20)16-8-2-4-14-22(16)26;1-12-6-5-9-16-14(12)10-11-15(17-16)13-7-3-2-4-8-13;1-2-8-13-12(6-1)7-5-9-14(13)15-10-3-4-11-16-15;1-2-7-13(8-3-1)15-14-9-5-4-6-12(14)10-11-16-15;1-2-6-12(7-3-1)15-11-10-13-8-4-5-9-14(13)16-15;1-6-10-8(12-11-6)7-4-2-3-5-9-7;2*1-4(6)3-5(2)7;2*1-2;;;;;;/h1-14,25-26H;2-7,9-11H,1H3;1-8,10-11H;1-7,9-11H;1-6,8-11H;2-5H,1H3;2*3,6H,1-2H3;2*1H;;;;;;/q;5*-1;;;2*-1;+1;;;;;/p+1 |
| InChIKey | FBJVSRIBIBSDQX-UHFFFAOYSA-O |
| XLogP | 18.75 |
| TPSA | 280.56 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 127 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2686.72 |
| LogP ≤ 5 | 18.75 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159025360 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.